These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20664976)

  • 21. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC.
    Congrains A; Kamide K; Katsuya T; Yasuda O; Oguro R; Yamamoto K; Ohishi M; Rakugi H
    Biochem Biophys Res Commun; 2012 Mar; 419(4):612-6. PubMed ID: 22382030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease.
    Rodríguez-Esparragón F; Torres-Mata LB; Cazorla-Rivero SE; Serna Gómez JA; González Martín JM; Cánovas-Molina Á; Medina-Suárez JA; González-Hernández AN; Estupiñán-Quintana L; Bartolomé-Durán MC; Rodríguez-Pérez JC; Varas BC
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
    Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Splice variants of lncRNA RNA ANRIL exert opposing effects on endothelial cell activities associated with coronary artery disease.
    Cho H; Li Y; Archacki S; Wang F; Yu G; Chakrabarti S; Guo Y; Chen Q; Wang QK
    RNA Biol; 2020 Oct; 17(10):1391-1401. PubMed ID: 32602777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA‑202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN‑5.
    Li YG; He JH; Yu L; Hang ZP; Li W; Shun WH; Huang GX
    Mol Med Rep; 2014 Feb; 9(2):541-6. PubMed ID: 24337320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
    Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
    Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1.
    Cornella N; Tebaldi T; Gasperini L; Singh J; Padgett RA; Rossi A; Macchi P
    J Biol Chem; 2017 Dec; 292(48):19674-19692. PubMed ID: 28972179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Noncoding RNA
    Holdt LM; Teupser D
    Front Cardiovasc Med; 2018; 5():145. PubMed ID: 30460243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
    Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
    J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells.
    Fang MA; Glackin CA; Sadhu A; McDougall S
    J Cell Biochem; 2001; 80(4):550-9. PubMed ID: 11169739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular regulation of KIR3DL1 gene expression by transcription factor E2F1].
    Gao XN; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):806-10. PubMed ID: 19176033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of p14ARF by E2F1 contributes to 8-chloro-adenosine-induced apoptosis in human lung cancer H1299 cells.
    Li WJ; Gu YY; Zhang HJ; Zhou J; Jia HT
    Chemotherapy; 2009; 55(5):335-43. PubMed ID: 19641316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10.
    Bochenek G; Häsler R; El Mokhtari NE; König IR; Loos BG; Jepsen S; Rosenstiel P; Schreiber S; Schaefer AS
    Hum Mol Genet; 2013 Nov; 22(22):4516-27. PubMed ID: 23813974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV.
    Vázquez-Vega S; Sánchez-Suárez LP; Contreras-Paredes A; Castellanos-Juárez E; Peñarroja-Flores R; Lizano-Soberón M; Andrade-Cruz R; García-Carrancá A; Benítez-Bribiesca L
    Cancer Biomark; 2010-2011; 8(6):341-50. PubMed ID: 22072122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear speckle-associated protein Pnn/DRS binds to the transcriptional corepressor CtBP and relieves CtBP-mediated repression of the E-cadherin gene.
    Alpatov R; Munguba GC; Caton P; Joo JH; Shi Y; Shi Y; Hunt ME; Sugrue SP
    Mol Cell Biol; 2004 Dec; 24(23):10223-35. PubMed ID: 15542832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical and Functional Studies Identify Epistasis of Cardiovascular Risk Genomic Variants From Genome-Wide Association Studies.
    Li Y; Cho H; Wang F; Canela-Xandri O; Luo C; Rawlik K; Archacki S; Xu C; Tenesa A; Chen Q; Wang QK
    J Am Heart Assoc; 2020 Apr; 9(7):e014146. PubMed ID: 32237974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
    Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
    Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kong Y; Hsieh CH; Alonso LC
    Front Endocrinol (Lausanne); 2018; 9():405. PubMed ID: 30087655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.